Dr. Kremyanskaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1190 5th Avenue
New York, NY 10029Phone+1 212-241-6756Fax+1 212-423-0522- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2009 - 2012- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
NY State Medical License 2008 - 2024- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) Start of enrollment: 2013 Jan 01
- Ruxolitinib in Combination With Autotransplant Start of enrollment: 2015 May 01
- A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2020 Jun 12
- Join now to see all
Publications & Presentations
PubMed
- Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Pro...Joseph Tripodi, Ronald Hoffman, Daiva Ahire, Vesna Najfeld, Douglas Tremblay, John Mascarenhas, Marina Kremyanskaya> ;International Journal of Molecular Sciences. 2024 Apr 5
- Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati G...> ;Blood Advances. 2024 Mar 26
- Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.Adegbite, B., Abramson, M., Gutgarts, V., Musteata, F., Chauhan, K., Muwonge, A., Meliambro, K., Salvatore, S., El Ghaity-Beckley, S., Kremyanskaya, M., Marcellino, B....> ;Clinical Journal of the American Society of Nephrology. 2023 Sep 1
- Join now to see all
Press Mentions
Protagonist Therapeutics Announces Presentation of Updated Results from Phase 2 Study of Rusfertide in Polycythemia Vera, Selected for Oral Presentation at EHA 2021May 12th, 2021- Hepcidin Mimetic Eliminates Need for Phlebotomy in Polycythemia VeraDecember 18th, 2020
- Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual MeetingNovember 4th, 2020
- Join now to see all
Hospital Affiliations
The Mount Sinai HospitalNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
